GRCE
GRCE
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
1
$136K
Insider Sales
0
$0
Total Volume
$136K
6 transactions
Net Activity
+$136K
Net buying
Sentiment Rating
Moderate AccumulationCEO Conviction Index
No Recent Signal
Key Drivers
- •Strong buying bias: purchases represent 100% of total transaction value.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Multiple Insiders
P - Purchase Insiders
$151.48B total
Opaleye Management Inc.
10%
$136K total
Quick Actions
GRCE has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%.
Over the last 90 days, corporate insiders at GRCE (GRCE) engaged in a total of 6 transactions reported via SEC Form 4 filings. Among these, 1 were open-market purchases and 0 were sales. The total volume of insider trading reached $136K.
The net insider activity for GRCE shows a net buying bias of $136K. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 2.86M shares valued at $43.08B on Sep 21, 2026.
Grace Therapeutics (GRCE) 10% owner Opaleye Management bought 48,060 shares for $83.4K at an average $1.74
Opaleye Management buys $83,435 in Grace Therapeutics stock
Across three purchases, Opaleye, L.P. bought 48,060 shares of Grace Therapeutics (GRCE).
GRCE - Grace Therapeutics Inc Stock Price and Quote
GRCE Stock Price and Chart — NASDAQ:GRCE
FDA declines Grace's stroke drug over manufacturing and packaging issues, shares slump
FAQs About GRCE Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for GRCE.